Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: A report from the children's oncology group

Journal of Clinical Oncology

Volumn 29, Issue 10, 2011, Pages 1304-1311

  Rodeberg, David A ^{a,b,c,d,e,f,g,h,i,j,k,l}   Garcia Henriquez, Norbert ^{a,b,c,d,e,f,g,h,i,j,k}   Lyden, Elizabeth R ^{a,b,c,d,e,f,g,h,i,j,k}   Davicioni, Elai ^{a,b,c,d,e,f,g,h,i,j,k}   Parham, David M ^{a,b,c,d,e,f,g,h,i,j,k}   Skapek, Stephen X ^{a,b,c,d,e,f,g,h,i,j,k}   Hayes Jordan, Andrea A ^{a,b,c,d,e,f,g,h,i,j,k}   Donaldson, Sarah S ^{a,b,c,d,e,f,g,h,i,j,k}   Brown, Kenneth L ^{a,b,c,d,e,f,g,h,i,j,k}   Triche, Timothy J ^{a,b,c,d,e,f,g,h,i,j,k}   Meyer, William H ^{a,b,c,d,e,f,g,h,i,j,k}   Hawkins, Douglas S ^{a,b,c,d,e,f,g,h,i,j,k}  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^g CHILDREN S HOSPITAL LOS ANGELES   (United States)

^h SEATTLE CHILDREN S HOSPITAL   (United States)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j GenomeDx Biosciences Inc   (Canada)

^k BC CHILDREN S HOSPITAL   (Canada)

^l EAST CAROLINA UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; ARTICLE; CANCER SURVIVAL; CHILD; DISEASE SEVERITY; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; REGIONAL LYMPH NODE DISEASE; RHABDOMYOSARCOMA; SCHOOL CHILD;

CANADA; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RHABDOMYOSARCOMA, ALVEOLAR; RHABDOMYOSARCOMA, EMBRYONAL; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 79954433581     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.29.4611     Document Type: Article

References (24)

1. Gurney JG, Young JL, Roffers SD, et al: Soft tissue sarcomas, in: SEER Pediatric Monograph. Bethesda, MD, National Cancer Institute, 1999
2. Raney RB, Anderson JR, Barr FG, et al: Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: A selective review of Intergroup Rhabdomyosarcoma Study Group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol 23:215-220, 2001 (Pubitemid 32524925)
3. Pappo AS, Shapiro DN, Crist WM, et al: Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol 13:2123-2139, 1995
4. Breneman JC, Lyden E, Pappo AS, et al: Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 21:78-84, 2003
5. Oberlin O, Rey A, Lyden E, et al: Prognostic factors in metastatic rhabdomyosarcomas: Result of a pooled analysis from United States and European cooperative groups. J Clin Oncol 26:2384-2389, 2008
6. Meza JL, Anderson J, Pappo AS, et al: Analysis of prognostic factors in patients with non-metastatic rhabdomyosarcoma treated on Intergroup Rhabdomyosarcoma studies III and IV: The Children's Oncology Group. J Clin Oncol 24:3844-3851, 2006 (Pubitemid 46630730)
7. Donaldson SS, Meza J, Breneman JC, et al: Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma: A report from the IRSG. Int J Radiat Oncol Biol Phys 51:718-728, 2001
8. Neville HL, Andrassy RJ, Lobe TE, et al: Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: A preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997). J Pediatr Surg 35:317-321, 2000 (Pubitemid 30082591)
9. Crist WM, Anderson JR, Meza JL, et al: Intergroup Rhabdomyosarcoma Study-IV: Results for patients with nonmetastatic disease. J Clin Oncol 19:3091-3102, 2001 (Pubitemid 32567502)
10. Kaplan GL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
11. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 35:1-39, 1977 (Pubitemid 8018922)
12. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
13. Davicioni E, Anderson MJ, Finckenstein FG, et al: Molecular classification of rhabdomyosarcoma: Genotypic and phenotypic determinants of diagnosis-A report from the Children's Oncology Group. Am J Pathol 174:550-564, 2009
14. National Cancer Institute: caArray: Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas. https://array.nci.nih.gov/caarray/project/trich- 00099
15. Davicioni E, Finckenstein FG, Shahbazian V, et al: Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas. Cancer Res 66:6936-6946, 2006 (Pubitemid 44197668)
16. Huang da W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57, 2009
17. Dennis G Jr, Sherman BT, Hosack DA, et al: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3, 2003
18. Carli M, Colombatti R, Oberlin O, et al: European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: Final results and analysis of prognostic factors. J Clin Oncol 22:4787-4794, 2004
19. Rodary C, Gehan EA, Flamant F, et al: Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: A report from the International Rhabdomyosarcoma Workshop. Med Pediatr Oncol 19:89-95, 1991
20. Bergeron C, Thiesse P, Rey A, et al: Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: An up-front window study in newly diagnosed children with high-risk metastatic disease. Eur J Cancer 44:427-431, 2008
21. Rickman DS, Millon R, De Reynies A, et al: Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays. Oncogene 27:6607-6622, 2008
22. Kashiwazaki H, Hassan NM, Hamada J, et al: Gene expression profile changes correlated with lymph node metastasis in oral squamous cell carcinoma. Odontology 96:38-43, 2008
23. Tamoto E, Tada M, Murakawa K, et al: Geneexpression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer. Clin Cancer Res 10:3629-3638, 2004 (Pubitemid 38697596)
24. Chen Z, Huang X, Ye J, et al: Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades. Cancer 116:1953-1963, 2010